Detalles de la búsqueda
1.
Rate of non-response to ursodeoxycholic acid in a large real-world cohort of primary biliary cholangitis patients in Italy.
Scand J Gastroenterol
; 54(10): 1274-1282, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31564176
2.
Long term nucleotide and nucleoside analogs treatment in chronic hepatitis B HBeAg negative genotype D patients and risk for hepatocellular carcinoma.
Ann Hepatol
; 13(4): 376-85, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24927608
3.
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b.
BMC Gastroenterol
; 12: 162, 2012 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-23157720
4.
Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial.
BMC Gastroenterol
; 10: 21, 2010 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-20170514
5.
Sustained virological response in patients with HCV treated with daclatasvir plus sofosbuvir, with or without ribavirin: a large, field-practice study.
Drugs Context
; 92020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33408749
6.
Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon alpha-2a and ribavirin: a multicentric study.
Liver Int
; 29(10): 1479-84, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19422478
7.
Peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a monotherapy in early virological responders and peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a, ribavirin and amantadine triple therapy in early virological nonresponders: the SMIEC II trial in naïve patients with chronic hepatitis C.
Eur J Gastroenterol Hepatol
; 20(7): 680-7, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18679072
8.
HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets.
Viruses
; 10(7)2018 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29987240
9.
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro.
Oncotarget
; 8(9): 15704-15715, 2017 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-28152517
10.
Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study.
Clin Ther
; 30(2): 317-23, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18343270
Resultados
1 -
10
de 10
1
Próxima >
>>